about
Cardiovascular risks in smokers treated with nicotine replacement therapy: a historical cohort study.Leicester Cough Questionnaire: translation to Portuguese and cross-cultural adaptation for use in Brazil.Reliability of a rapid hematology stain for sputum cytology.Disparate geographic prevalences of asthma, allergic rhinoconjunctivitis and atopic eczema among adolescents in five Canadian cities.Fluticasone/formoterol dry powder versus budesonide/formoterol in adults and adolescents with uncontrolled or partly controlled asthma.Temporal trends in the prevalence of asthma and rhinoconjunctivitis in adolescents.Limited agreement between written and video asthma symptom questionnaires.Is the COPD Assessment Test sensitive for differentiating COPD patients from active smokers and nonsmokers without lung function impairment? A population-based studyMonitoring sputum eosinophils in mucosal inflammation and remodelling: a pilot studyIs sputum eosinophilia a good or poor predictor of benefit from inhaled corticosteroid therapy in asthma?Diagnosing occupational asthma: use of induced sputumInduced Sputum in the Management of AsthmaEffect of salmeterol compared with beclomethasone on allergen-induced asthmatic and inflammatory responsesHow does the GINA definition of control correlate with quality of life and sputum cellularity?2020 Brazilian Thoracic Association recommendations for the management of asthmaTranslation and cultural adaptation of the King's Brief Interstitial Lung Disease health status questionnaire for use in BrazilBody mass index, asthma, and respiratory symptoms: a population-based studyPrescribing trends in and perceptions of the treatment of asthma: a survey among pulmonologists in BrazilCelebrating World Asthma Day in Brazil: is the glass half full or half empty?Prevalence of smoking and reasons for continuing to smoke: a population-based studyMeasures of frequency: calculating prevalence and incidence in the era of COVID-19
P50
Q33627663-4389C9A5-36A2-4FFA-B5AF-2A39ECC61B6EQ33942886-77612BF7-BB46-4083-92E8-3A863BC5A397Q33942911-81C417D0-87B2-4873-A86A-7A2BA7CD95BBQ34619803-AE5238F5-5AD4-4CC3-A405-131F4F2E9F62Q34654210-D5C3BF75-0448-49EF-981D-36146A883887Q36473276-F6816D84-96C1-47FF-8235-C589AAA958EAQ44631751-01EC4349-6BC3-4A58-B96D-C12A7C801456Q44631751-5C68EB39-0831-4CE7-94C6-EE270585B7D2Q60412535-5040180B-228B-41A1-ADAD-1C44C8227199Q60412615-5DE0AE9F-6A64-4538-934C-227D9225334BQ60412703-9CFB06B7-BBDB-4D11-9510-5C66AE8AC384Q60412756-DA07C130-F91B-4F53-B941-DA645FD6CC2FQ60412943-DB19D1B9-477F-42D4-96B4-CAD71410DAC5Q60412975-6833342B-29C9-4AD4-8BFB-12439B42DF6AQ61799957-A524B136-538C-4D5C-9368-CAA1786547FCQ90040504-E6FE6A3A-D11C-419D-9D93-B1EABDA995F9Q90154779-CC8E613C-6AEE-46BB-AC4A-D8C5BC81F1A8Q92145754-A22C4915-C135-4DB3-9A58-937B3C33FCE5Q92312261-4D07D937-CD4B-49FF-A472-68C6DB041DD1Q92538753-12066675-F612-4696-A45B-DFB73AA25BAFQ92813158-D640C6FB-C85B-4577-8BDD-1820ACBDB2D2Q96579335-76542BE5-B6CD-49B4-8A65-ECCC14C0784E
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Marcia Pizzichini
@ast
Marcia Pizzichini
@en
Marcia Pizzichini
@es
Marcia Pizzichini
@nl
Marcia Pizzichini
@sl
type
label
Marcia Pizzichini
@ast
Marcia Pizzichini
@en
Marcia Pizzichini
@es
Marcia Pizzichini
@nl
Marcia Pizzichini
@sl
altLabel
Pizzichini M Pizzichini MMM, Pizzichini MM
@en
prefLabel
Marcia Pizzichini
@ast
Marcia Pizzichini
@en
Marcia Pizzichini
@es
Marcia Pizzichini
@nl
Marcia Pizzichini
@sl
P1053
K-5168-2013
P106
P21
P31
P3829
P496
0000-0001-7409-7536